Article info
Original research
Trial of aerosolised surfactant for preterm infants with respiratory distress syndrome
- Correspondence to Dr David Durand, Neonatology, UCSF Benioff Children's Hospital Oakland, Oakland, CA 94752, USA; ddurand53{at}gmail.com
Citation
Trial of aerosolised surfactant for preterm infants with respiratory distress syndrome
Publication history
- Received January 17, 2021
- Revised April 24, 2021
- Accepted April 27, 2021
- First published June 10, 2021.
Online issue publication
December 15, 2021
Article Versions
- Previous version (10 June 2021).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.